Cquis1 t1_ixfpr0c wrote on November 23, 2022 at 2:25 AM Reply to Three currently circulating omicron subvariants of SARS-CoV-2 – including two that currently make up almost 50% of reported COVID-19 infections in the U.S. – are better at evading vaccine- and infection-generated neutralizing antibodies than earlier versions of omicron, new research suggests. by memorialmonorail Trust the science, don’t ask questions! Permalink −25−
Cquis1 t1_ixfpr0c wrote
Reply to Three currently circulating omicron subvariants of SARS-CoV-2 – including two that currently make up almost 50% of reported COVID-19 infections in the U.S. – are better at evading vaccine- and infection-generated neutralizing antibodies than earlier versions of omicron, new research suggests. by memorialmonorail
Trust the science, don’t ask questions!